Spark Investment Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Spark Investment Management’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-38,100	Closed	-$419K	–	939
2017 Q1	$419K	Sell	38,100 -3,200	-8%	-$37.1K	0.03%	569
2016 Q4	$559K	Buy	+41,300	New	+$576K	0.05%	466
2016 Q2	–	Sell	-140,388	Closed	-$1.53M	–	910
2016 Q1	$1.53M	Buy	140,388 +76,788	+121%	+$970K	0.16%	215
2015 Q4	$1.1M	Sell	63,600 -25,100	-28%	-$450K	0.14%	221
2015 Q3	$1.76M	Sell	88,700 -24,500	-22%	-$562K	0.23%	135
2015 Q2	$1.86M	Buy	113,200 +18,600	+20%	+$323K	0.26%	118
2015 Q1	$1.47M	Buy	94,600 +50,900	+116%	+$789K	0.21%	161
2014 Q4	$623K	Buy	43,700 +2,500	+6%	+$26.4K	0.1%	276
2014 Q3	$267K	Buy	41,200 +17,200	+72%	+$114K	0.04%	469
2014 Q2	$164K	Buy	+24,000	New	+$170K	0.02%	512
2013 Q3	–	Sell	-25,400	Closed	-$167K	–	618
2013 Q2	$167K	Buy	+25,400	New	+$202K	0.04%	357

Other funds holding SCMP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Spark Investment Management's SCMP Position: Q2 2017 in Review

Spark Investment Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q2 2017, closing a stake of 38,100 shares — an estimated $419K sold.

Spark Investment Management first reported a position in SCMP in Q2 2013 and held it in 11 quarters. The position peaked at $1.86M in Q2 2015. 167 funds tracked by Wall St. Rank hold SCMP as of Q2 2017.

Spark Investment Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
Spark Investment Management sold 38,100 Sucampo Pharmaceuticals, Inc. shares in Q2 2017, an estimated $419K.
Spark Investment Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 11 quarters.
Spark Investment Management's Sucampo Pharmaceuticals, Inc. position peaked at $1.86M in Q2 2015.
167 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q2 2017.

Based on Spark Investment Management's 13F filing for Q2 2017, filed 27 Jul 2017.